Elanco Animal Health ELAN
NYSE ELAN
$26.41 -0.37 (-1.38%)
At close: Nov 16, 2026 · 4:00 PM EST

Elanco Animal Health (ELAN) Gains (Losses) on Sale of Assets & Investments (2024)

Updated

Elanco Animal Health's Gains (Losses) on Sale of Assets & Investments came in at $640 million for FY2024.

Analysis

Elanco Animal Health (ELAN) Gains (Losses) on Sale of Assets & Investments (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Elanco Animal Health 13.25 Bn 11.29 Bn 720.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 640.00 Mn
API Access

Elanco Animal Health Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ELAN&period=max&api_key=YOUR_API_KEY